About Us
Our People
Board of Directors
Our Product
In Development
Mission
Investors
Careers
Contact
Contact Us
Media Contact
Investor Contact
Investors
Investors Home
Stock Quote
Stock Information
Historical Stock Price
News Releases
Events and Presentations
SEC Filings
Analyst Coverage
Corporate Governance
Board of Directors
Charters & Code of Ethics
FAQs
Investor Contacts & Alerts
Investors Home
Stock Quote
News Releases
Events and Presentations
SEC Filings
Analyst Coverage
Corporate Governance
FAQs
Investor Contacts & Alerts
News Releases
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Oct 17, 2017
Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company
Jul 27, 2017
Evofem Biosciences Announces First Patient Enrolled in a Phase 3 Clinical Trial of AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) for Prevention of Pregnancy
Jun 29, 2017
AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) Receives "Qualified Infectious Disease Product" (QIDP) Designation from the FDA
Dec 16, 2016
Evofem Biosciences Appoints Dr. David Friend as Chief Scientific Officer
Aug 29, 2016
Evofem Biosciences Appoints Russell Barrans as Chief Commercial Officer
Aug 17, 2016
Evofem Biosciences Announces First Patient Enrolled in a Clinical Trial to Determine the Effect and Duration of Amphora Gel on Vaginal pH
Aug 4, 2016
Evofem secures $25 million in Series D funding
EVOFEM SECURES $25.0 MILLION IN SERIES D FUNDING
Jun 15, 2016
Evofem to Address the Cavendish Global Health Impact Forum at Biocom on Innovations in Reproductive Health Care around the globe.
May 16, 2016
Evofem and WomanCare Global to Attend Women Deliver 2016
Largest conference on health, rights, and wellbeing of girls and women with focus on solutions
Mar 31, 2016
Evofem Files IND for Evaluation of Prevention of Recurrence of Bacterial Vaginosis
Feb 9, 2016
Evofem and DKT to Develop Coated Condom
Jan 11, 2016
Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora®
Jan 6, 2016
Evofem, Inc. Expands Management Team
Sep 22, 2015
Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora™ as a Contraceptive
Jul 30, 2015
Evofem, Inc. Appoints Russell Barrans as Vice President of Sales and Marketing for North America
Jul 6, 2015
Evofem, Inc. Submits New Drug Application to U.S. FDA for Amphora™ as a Contraceptive
Jul 1, 2015
Evofem, Inc. Appoints Dr. Kelly Culwell as Chief Medical Officer
Apr 14, 2015
Woman Care Global & Evofem CEO Saundra Pelletier Announced as Speaker for UVA Darden School of Business’ Leadership Speaker Series
Apr 1, 2015
Evofem, Inc. Appoints Dr. David Friend as Senior Vice President of Product Development
Jan 13, 2015
Evofem, Inc. Announces Pre-NDA Meeting With FDA for Amphora™
Jun 26, 2014
Evofem Announces the Completion of a Phase III Contraceptive Clinical Trial
Show
5
10
25
50
100
per page
«
1
2
3
4
5
»